Stem cell-derived exosomes (SC-EXO) was an emerging therapeutic agent in regenerative medicine. Intratunical injection of SC-EXO is considered as a prospective approach for erectile dysfunction (ED) treatment. However, high vascularization of cavernous body makes effective retention a major challenge for SC-EXO intratunical injection. In this study, a Polydopamine nanoparticles (PDNPs) incorporated poly (ethylene glycol)-poly(ε-caprolactone-co-lactide) (PDNPs-PELA) thermosensitive hydrogels were fabricated by a facile in situ polymerization for intratunical administration of adipose stem cell-derived exosomes (EXO). The hydrogels exhibited sol-gel transition at body temperature. Moreover, the in-situ polymerization of PDNPs using poly (ethylene glycol)-poly(ε-caprolactone-co-lactide) (PELA) block copolymer as a template was found to be more stable dispersion in the gel system. After being encapsulated into the hydrogel, EXO shows sustained release behavior within two weeks. In vivo animal experiments revealed that exosomes released from hydrogel lead to the healing of endothelial cells and neurons, increase of the cavity's pressure, thereby restoring the erectile function. In particular, since the PDNPs in thermosensitive gels have excellent photoacoustic performance, the hydrogel can be accurately delivered into the tunica albuginea by the guidance of real-time photoacoustic imaging. These results suggest that the as-prepared PDNPs-PELA has a promising future as an injectable exosome carrier for ED treatment.
7 October 2024 in International Immunopharmacology
BACKGROUND—Repeated episodes of atrial fibrillation (AF) can shorten event-free survival time in patients. Patient-reported outcomes (PROs) directly reflect the health status of patients. However, the relationship between PROs and cardiac event-free survival remains unclear. OBJECTIVE—This study aimed to investigate the status of PROs and their correlation with cardiac event-free survival time in patients with AF. METHODS—This study was a prospective study. Patients with non-valvular atrial fibrillation treated in the Department of Cardiology of one three third-class hospital in Yancheng from May 2023 to April 2024 were enrolled. The investigation was performed using general information questionnaire and AF-specific questionnaire 6 (AF6). At baseline, demographic and clinical data of the patients were collected. Major adverse cardiovascular events and one-year event-free survival time after discharge were obtained by telephone follow-ups and review of medical records. RESULTS— Among the 197 patients investigated, the mean age was (74.1 ± 9.0) years old, and 106 (53.8%) were women. The mean AF6 score was (24.29 ± 8.33), with over 50% of patients scoring ≥ 1 point on all six items. A significant correlation was observed between cardiac function grading and PROs (r = 0.360, P < 0.001). Kaplan-Meier plots and log-rank tests demonstrated that patients with poor PROs had significantly worse cardiac event-free survival (P = 0.043). CONCLUSION—The PROs of patients with AF were at a moderate level. Poor PROs were associated with the shorter cardiac event-free survival times. These findings highlight the requirement for intervention studies aimed at improving PROs. Clinical trial number Not applicable.